Background illustration for clinical trials search

Paid Clinical Trials Toronto

Discover 2,121 paid clinical trials in Toronto, Ontario. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.

Filter
2

Phase III Study of Datopotamab Deruxtecan Versus Docetaxel in Previously Treated TROP2-positive Advanced or Metastatic Non-squamous NSCLC Without Actionable Genomic Alterations

for
Non-small Cell Lung Cancer (NSCLC)
Location: Toronto, Brampton, Hamilton, East Syracuse NY,
Sponsor: AstraZeneca

Sex: All

Age: 18+

Code: NCT07291037

Phase 3, Recruiting

Study of RYZ401 in Subjects With Solid Tumors Expressing SSTRs.

for
GEP-NET, Gastroenteropancreatic Neuroendocrine Tumor,
Location: Toronto, Montreal, Columbus OH, Charlottesville VA,
Sponsor: RayzeBio, Inc.

Sex: All

Age: 18+

Code: NCT07165132

Phase 1, Recruiting

Sonesitatug Vedotin in Combination With Capecitabine With or Without Rilvegostomig in Participants With Advanced or Metastatic Gastric, Gastroesophageal Junction, or Esophageal Adenocarcinoma Expressing Claudin18.2

for
Gastric Cancer, Gastroesophageal Junction Adenocarcinoma,
Location: Toronto, Brampton, Barrie, Ottawa, Pittsburgh PA,
Sponsor: AstraZeneca

Sex: All

Age: 18+

Code: NCT07431281

Phase 3, Recruiting

A Study of Rilvegostomig or Durvalumab Plus Chemotherapy for First-Line Treatment of Biliary Tract Cancer (ARTEMIDE-Biliary02)

for
Biliary Tract Cancer
Location: Toronto, Barrie, Pittsburgh PA, Lancaster PA, Montreal,
Sponsor: AstraZeneca

Sex: All

Age: 18+

Code: NCT07221253

Phase 3, Recruiting

Study of AZD4512 Monotherapy or in Combination With Anticancer Agents in Participants With Acute Lymphoblastic Leukemia

for
B-cell Acute Lymphoblastic Leukemia (B-ALL)
Location: Toronto, Chicago IL, Iowa City IA, Franklin TN,
Sponsor: AstraZeneca

Sex: All

Age: 12+

Code: NCT07109219

Phase 1, Phase 2, Recruiting

Interested in new trials?

Get alerts for new trials in your area by subscribing now

Subscriber Image

Safety and Efficacy of Tarperprumig in Adult Participants With Anti-Neutrophil Cytoplasmic Antibody (ANCA)-Associated Vasculitis

for
Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis
Location: Etobicoke, Toronto, Hamilton, Montreal, Edmonton,
Sponsor: Alexion Pharmaceuticals, Inc.

Sex: All

Age: 18 - 70+

Code: NCT07160608

Phase 2, Recruiting

A Study of Surovatamig (AZD0486) Plus Rituximab in Previously Untreated Follicular Lymphoma Patients

for
Untreated Follicular Lymphoma
Location: Toronto, Oshawa, Hamilton, Albany NY, Saint-Jerôme,
Sponsor: AstraZeneca

Sex: All

Age: 18 - 70+

Code: NCT06549595

Phase 3, Recruiting

A Study to Find Out if the Study Drug Elecoglipron Helps Adults With Type 2 Diabetes Mellitus by Comparing it With Semaglutide, a Medicine Already Used to Treat Type 2 Diabetes Mellitus

for
Type 2 Diabetes Mellitus
Location: Toronto, Scarborough Village, Stouffville, Sarnia,
Sponsor: AstraZeneca

Sex: All

Age: 18+

Code: NCT07662213

Phase 3, Recruiting

Study of ARO-MAPT-SC in Healthy Participants and Participants With Early Alzheimer's Disease

for
Alzheimer Disease, Alzheimer Disease, Early Onset
Location: Toronto, East York, Montreal
Sponsor: Arrowhead Pharmaceuticals

Sex: All

Age: 18 - 70+

Code: NCT07221344

Phase 1, Phase 2, Recruiting

A Phase 1b/2 Study of CAR T Cell Therapy Targeting CD19 and BCMA in Participants With Relapsed or Refractory AL Amyloidosis.

for
Relapsed AL Amyloidosis, Refractory AL Amyloidosis,
Location: Toronto, Cleveland OH, Detroit MI, New York NY,
Sponsor: Alexion Pharmaceuticals, Inc.

Sex: All

Age: 18+

Code: NCT07081646

Phase 1, Phase 2, Recruiting

A Phase III Study of AZD0780 on Major Adverse CV Events in Patients With a History of ASCVD Events or at High Risk for a First Event

for
Cardiovascular Disease
Location: Toronto, Etobicoke, Scarborough Village, North York,
Sponsor: AstraZeneca

Sex: All

Age: 18+

Code: NCT07000357

Phase 3, Recruiting

Phase III Study of Rilvegostomig in Combination With Bevacizumab With or Without Tremelimumab as First-line Treatment of Hepatocellular Carcinoma

for
Hepatocellular Carcinoma
Location: Toronto, Brampton, Barrie, Detroit MI, Pittsburgh PA,
Sponsor: AstraZeneca

Sex: All

Age: 18+

Code: NCT06921785

Phase 3, Recruiting

LUNG-ROLL: Treatment Patterns and Cost of Illness of Lung Cancer in Canada

for
Lung Neoplasms
Location: Toronto, Calgary
Sponsor: AstraZeneca

Sex: All

Age: 18 - 70+

Code: NCT07143110

Recruiting

Effect of Dalcetrapib on CV Risk in a Genetically Defined Population With a Recent ACS

for
Acute Coronary Syndrome
Location: Toronto, Scarborough Village, Newmarket, Cambridge,
Sponsor: DalCor Pharmaceuticals

Sex: All

Age: 45+

Code: NCT05918861

Phase 3, Recruiting

Surovatamig (AZD0486) as Monotherapy in Participants With Relapsed/Refractory (R/R) B-cell NHL

for
B-cell Non-Hodgkin Lymphoma, Follicular Lymphoma (FL),
Location: Toronto, Brampton, Ottawa, Pittsburgh PA, Columbus OH,
Sponsor: AstraZeneca

Sex: All

Age: 18+

Code: NCT06526793

Phase 2, Recruiting

A Global Phase III Study of Rilvegostomig or Pembrolizumab Monotherapy for First-Line Treatment of PD-L1-high Metastatic Non-small Cell Lung Cancer

for
Carcinoma, Non-Small Cell Lung
Location: Toronto, Buffalo NY, East Syracuse NY, Morgantown WV,
Sponsor: AstraZeneca

Sex: All

Age: 18+

Code: NCT06868277

Phase 3, Recruiting

Study of Volrustomig in Women With High Risk Locally Advanced Cervical Cancer (eVOLVE-Cervical)

for
Locally Advanced Cervical Cancer
Location: Toronto, Hamilton, Montreal
Sponsor: AstraZeneca

Sex: Female

Age: 15+

Code: NCT06079671

Phase 3, Recruiting

Study to Evaluate the Effect of Balcinrenone/Dapagliflozin in Patients With Heart Failure and Impaired Kidney Function

for
Heart Failure and Impaired Kidney Function
Location: Toronto, North York, Newmarket, Hamilton, Cambridge,
Sponsor: AstraZeneca

Sex: All

Age: 18 - 70+

Code: NCT06307652

Phase 3, Recruiting

A Phase III Study of Dato-DXd With or Without Durvalumab Compared With Investigator's Choice of Chemotherapy in Combination With Pembrolizumab in Patients With PD-L1 Positive Locally Recurrent Inoperable or Metastatic Triple-negative Breast Cancer (TROPION-Breast05)

for
Breast Cancer
Location: Toronto, Hamilton, Barrie, Cleveland OH, Detroit MI,
Sponsor: AstraZeneca

Sex: All

Age: 18+

Code: NCT06103864

Phase 3, Recruiting

Efficacy and Safety of Tozorakimab in Patients Hospitalised for Viral Lung Infection Requiring Supplemental Oxygen

for
Viral Lung Infection and Acute Respiratory Failure
Location: Toronto, Brampton, Royal Oak MI, Detroit MI, Ottawa,
Sponsor: AstraZeneca

Sex: All

Age: 18+

Code: NCT05624450

Phase 3, Recruiting